The partnership is not expected to materially impact Livingstone’s NTA or EPS for FY2025 ending March 31, 2025.
Cove Aesthetics Medispa, a subsidiary of Singapore Exchange S68
(SGX)-listed Livingstone, has announced a strategic partnership with Skin Inc. Supplement Bar to provide personalised skincare solutions.
The partnership will tap on Cove Aesthetics Medispa’s expertise in advanced medical aesthetics and leverage Skin Inc.’s database of over 1 million skin and wellness profiles including over 250,000 face scans.
"Beauty is from the inside out, and we are excited to partner with Skin Inc, a brand that shares our commitment to innovation and personalized care. Together, we can offer our clients a truly transformative experience that goes beyond traditional aesthetic treatments,” says Dr. Rachel Lim, director and medical advisor at Cove Aesthetics Medispa.
“Our partnership with Cove Aesthetics aligns perfectly with our vision of providing 360-degree comprehensive skincare solutions. By combining our expertise in skincare formulations with Cove's medical aesthetics, we can deliver unparalleled results to our customers. We are excited to leverage our AI-driven insights to enhance the skincare journeys of our clients,” adds Sabrina Tan, CEO of Skin Inc.
The partnership is not expected to materially impact Livingstone’s net tangible assets (NTA) or earnings per share (EPS) for FY2025 ending March 31, 2025.
Shares in Livingstone closed 0.1 cent lower or 3.33% down at 2.9 cents on Oct 4.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.